Concord Asset Management (Virginia)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-715
Closed -$362K 148
2023
Q3
$362K Buy
715
+175
+32% +$93.3K 0.12% 97
2023
Q2
$282K Buy
540
+64
+13% +$34.5K 0.1% 105
2023
Q1
$274K Buy
+476
New +$268K 0.11% 89

Other funds holding TMO

Concord Asset Management (Virginia)'s TMO Position: Q4 2023 in Review

Concord Asset Management (Virginia) sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 715 shares — an estimated $362K sold.

Concord Asset Management (Virginia) first reported a position in TMO in Q1 2023 and held it in 3 quarters. The position peaked at $362K in Q3 2023. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Concord Asset Management (Virginia) reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Concord Asset Management (Virginia) sold 715 Thermo Fisher Scientific shares in Q4 2023, an estimated $362K.
  • Concord Asset Management (Virginia) first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 3 quarters.
  • Concord Asset Management (Virginia)'s Thermo Fisher Scientific position peaked at $362K in Q3 2023.
  • 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Concord Asset Management (Virginia)'s 13F filing for Q4 2023, filed 7 Nov 2024.